Sotera Health Company Statistics
Total Valuation
SHC has a market cap or net worth of $4.47 billion. The enterprise value is $6.42 billion.
| Market Cap | 4.47B |
| Enterprise Value | 6.42B |
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHC has 285.17 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Current Share Class | 285.17M |
| Shares Outstanding | 285.17M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 2.15% |
| Owned by Institutions (%) | 58.54% |
| Float | 192.56M |
Valuation Ratios
The trailing PE ratio is 38.34 and the forward PE ratio is 15.75.
| PE Ratio | 38.34 |
| Forward PE | 15.75 |
| PS Ratio | 3.76 |
| Forward PS | 3.54 |
| PB Ratio | 7.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 46.11 |
| P/OCF Ratio | 17.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.46, with an EV/FCF ratio of 66.31.
| EV / Earnings | 54.52 |
| EV / Sales | 5.40 |
| EV / EBITDA | 11.46 |
| EV / EBIT | 14.90 |
| EV / FCF | 66.31 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 3.65.
| Current Ratio | 2.82 |
| Quick Ratio | 2.36 |
| Debt / Equity | 3.65 |
| Debt / EBITDA | 3.96 |
| Debt / FCF | 23.44 |
| Interest Coverage | 2.88 |
Financial Efficiency
Return on equity (ROE) is 22.73% and return on invested capital (ROIC) is 9.69%.
| Return on Equity (ROE) | 22.73% |
| Return on Assets (ROA) | 8.51% |
| Return on Invested Capital (ROIC) | 9.69% |
| Return on Capital Employed (ROCE) | 14.23% |
| Weighted Average Cost of Capital (WACC) | 10.74% |
| Revenue Per Employee | $396,380 |
| Profits Per Employee | $39,265 |
| Employee Count | 3,000 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 8.25 |
Taxes
In the past 12 months, SHC has paid $87.14 million in taxes.
| Income Tax | 87.14M |
| Effective Tax Rate | 42.52% |
Stock Price Statistics
The stock price has increased by +27.27% in the last 52 weeks. The beta is 1.82, so SHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.82 |
| 52-Week Price Change | +27.27% |
| 50-Day Moving Average | 15.04 |
| 200-Day Moving Average | 16.22 |
| Relative Strength Index (RSI) | 53.84 |
| Average Volume (20 Days) | 4,526,920 |
Short Selling Information
The latest short interest is 14.25 million, so 5.00% of the outstanding shares have been sold short.
| Short Interest | 14.25M |
| Short Previous Month | 12.81M |
| Short % of Shares Out | 5.00% |
| Short % of Float | 7.40% |
| Short Ratio (days to cover) | 5.26 |
Income Statement
In the last 12 months, SHC had revenue of $1.19 billion and earned $117.79 million in profits. Earnings per share was $0.41.
| Revenue | 1.19B |
| Gross Profit | 657.17M |
| Operating Income | 431.01M |
| Pretax Income | 204.94M |
| Net Income | 117.79M |
| EBITDA | 560.15M |
| EBIT | 431.01M |
| Earnings Per Share (EPS) | $0.41 |
Balance Sheet
The company has $314.37 million in cash and $2.27 billion in debt, with a net cash position of -$1.96 billion or -$6.86 per share.
| Cash & Cash Equivalents | 314.37M |
| Total Debt | 2.27B |
| Net Cash | -1.96B |
| Net Cash Per Share | -$6.86 |
| Equity (Book Value) | 622.51M |
| Book Value Per Share | 2.18 |
| Working Capital | 378.17M |
Cash Flow
In the last 12 months, operating cash flow was $261.11 million and capital expenditures -$164.27 million, giving a free cash flow of $96.84 million.
| Operating Cash Flow | 261.11M |
| Capital Expenditures | -164.27M |
| Depreciation & Amortization | 129.14M |
| Net Borrowing | -85.89M |
| Free Cash Flow | 96.84M |
| FCF Per Share | $0.34 |
Margins
Gross margin is 55.26%, with operating and profit margins of 36.25% and 9.91%.
| Gross Margin | 55.26% |
| Operating Margin | 36.25% |
| Pretax Margin | 17.23% |
| Profit Margin | 9.91% |
| EBITDA Margin | 47.11% |
| EBIT Margin | 36.25% |
| FCF Margin | 8.14% |
Dividends & Yields
SHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
| Earnings Yield | 2.64% |
| FCF Yield | 2.17% |
Analyst Forecast
The average price target for SHC is $20.13, which is 28.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.13 |
| Price Target Difference | 28.18% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 6.68% |
| EPS Growth Forecast (5Y) | 48.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHC has an Altman Z-Score of 1.69 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.69 |
| Piotroski F-Score | 8 |